molybdenum has been researched along with Memory Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brewer, G; Cobb, KE; Domes, C; Harris, CJ; Quinn, JF; Ralle, M; Wadsworth, TL | 1 |
1 other study(ies) available for molybdenum and Memory Disorders
| Article | Year |
|---|---|
A copper-lowering strategy attenuates amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Blotting, Western; Cerebral Cortex; Ceruloplasmin; Chelating Agents; Copper; Enzyme-Linked Immunosorbent Assay; Hippocampus; Immunohistochemistry; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Molybdenum; Random Allocation | 2010 |